跳至主要内容
临床试验/NCT00555347
NCT00555347已完成2 期

Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis

University of Cincinnati1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2007年10月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
20
试验地点
1
主要终点
To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.

研究概览

简要总结

To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.

详细描述

The study will be divided into two halves. Patients will receive either drug or placebo in the first half. Patients receiving active drug will be started at one dose and it can be increased at the second visit. Those patients randomized to placebo will also have their dose adjusted by the investigating physician. The physicians will be blinded as to whether the patient is receiving drug or placebo. In the second half of the study, patients will receive the opposite treatment.

Patients will have complete detailed questionnaires regarding their fatigue, sleepiness, and overall quality of life.

They will have sleep studies done at the start and after each half of the study to determine the effect of therapy on sleepiness.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of sarcoidosis using standard criteria
  • Disease for more than one year
  • On stable, systemic therapy
  • Complain of fatigue which has been present for more than six months.
  • Over 18 years of age
  • Provide written informed consent.

排除标准

  • Pregnancy
  • Change in therapy for sarcoidosis in prior three months
  • History of ventricular arrythmias

研究组 & 干预措施

Armnodafinil

Active Comparator

Armodafinil

干预措施: Armodafinil (Drug)

Placebo

Placebo Comparator

干预措施: Placebo (Drug)

结局指标

主要结局

To determine the effect of Armodafinil (Nuvigil) on fatigue and sleep in sarcoidosis.

时间窗: Prospective

次要结局

  • To determine the safety and tolerability of Armodafinil (Nuvigil) in sarcoidosis.(Prospective)
  • To determine the effect of Armodafinil (Nuvigil) on pulmonary function in sarcoidosis.(Prospective)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Robert P Baughman

Prof Medicine

University of Cincinnati

研究点 (1)

Loading locations...

相似试验